AGMB logo

AgomAb Therapeutics N.V. American Depositary Shares

AGMB
Healthcare|Biotechnology|BE
$7.63
+0.67 (+9.54%)
DCF Value
$1.89
Tangible Book / Share
$4.86
Cash / Share
$5.17
Next Earnings Report
Mar 3, 2027
EPS est. -$0.95
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Feb 6, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Agomab to Participate in Upcoming Investor Conferences
Nov 4, 2026 · GlobeNewsWire
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
Oct 13, 2026 · GlobeNewsWire
Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease
Oct 1, 2026 · GlobeNewsWire
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Sep 14, 2026 · GlobeNewsWire
Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Sep 11, 2026 · GlobeNewsWire
Agomab to Participate in Upcoming Investor Conferences
Sep 3, 2026 · GlobeNewsWire
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Aug 10, 2026 · Globe News Wire

SEC Filings (27)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 13, 20266-KForeign issuer reportDocumentIndex
Oct 1, 20266-KForeign issuer reportDocumentIndex
Sep 14, 20266-KForeign issuer reportDocumentIndex
Sep 11, 20266-KForeign issuer reportDocumentIndex
Aug 10, 20266-KForeign issuer reportDocumentIndex
Aug 6, 20266-KForeign issuer reportDocumentIndex
Jun 23, 20266-KForeign issuer reportDocumentIndex
May 27, 20266-KForeign issuer reportDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 24, 20266-KForeign issuer reportDocumentIndex
Apr 23, 202620-FAnnual report (foreign)DocumentIndex
Apr 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 11, 2026S-8Employee stock planDocumentIndex
Mar 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 5, 20266-KForeign issuer reportDocumentIndex
Feb 17, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Feb 9, 20266-KForeign issuer reportDocumentIndex
Feb 6, 2026424B4Offering prospectusDocumentIndex
Feb 5, 2026CERTDocumentIndex
Feb 3, 20268-A12BDocumentIndex
Jan 30, 2026EFFECTDocumentIndex
Jan 29, 2026F-1/AIPO / offering registrationDocumentIndex
Jan 16, 2026F-1IPO / offering registrationDocumentIndex
Dec 17, 2025DRS/ADocumentIndex
Oct 28, 2025DRS/ADocumentIndex